Anne Sempowski Ward

Entity
Individual
Business address
C/O Vanda Pharmaceuticals Inc., 2200 Pennsylvania Avenue, Suite 300 E, 20037 Washington, DC
Insider ownership signature
/s/ Anne Sempowski Ward
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Anne Sempowski Ward has filed 18 SEC EDGAR filings since 10/28/2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 Jun 9, 2025 Jun 5, 2025 001-34186
4 Open Document Open Filing FORM 4 May 15, 2025 May 13, 2025 001-34702
4 Open Document Open Filing 4 May 21, 2024 May 17, 2024 001-34186
4 Open Document Open Filing FORM 4 May 20, 2024 May 16, 2024 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION Jun 12, 2023 Jun 8, 2023 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION May 16, 2023 May 12, 2023 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION Jun 21, 2022 Jun 16, 2022 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION May 19, 2022 May 17, 2022 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION Jun 14, 2021 Jun 10, 2021 001-34186
4/A Open Document Open Filing FORM 4/A SUBMISSION May 25, 2021 May 19, 2021 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION May 21, 2021 May 19, 2021 001-34702
4 Open Document Open Filing FORM 4 SUBMISSION Feb 23, 2021 Feb 19, 2021 001-34702
4 Open Document Open Filing FORM 4 Dec 23, 2020 Dec 22, 2020 001-04219
3 Open Document Open Filing FORM 3 SUBMISSION Nov 13, 2020 Nov 4, 2020 001-34702
3 Open Document Open Filing FORM 3 Oct 14, 2020 Oct 9, 2020 001-04219
4 Open Document Open Filing FORM 4 SUBMISSION Jun 15, 2020 Jun 11, 2020 001-34186
4 Open Document Open Filing FORM 4 SUBMISSION Oct 28, 2019 Oct 28, 2019 001-34186
3 Open Document Open Filing FORM 3 SUBMISSION Oct 28, 2019 Oct 28, 2019 001-34186